JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 18 No. 2 133-140
© 1977 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atkins, H. L.
Right arrow Articles by Ellis, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atkins, H. L.
Right arrow Articles by Ellis, K. J.

Thallium-201 for Medical Use. Part 3: Human Distribution and Physical Imaging Properties

H. L. Atkins, T. F. Budinger, E. Lebowitz*, A. N. Ansari, M. W. Greene, R. G. Fairchild and K. J. Ellis

Brookhaven National Laboratory, Upton, New York
Donner Laboratory, University of California, Berkeley, California

Correspondence: For reprints contact: Harold L. Atkins, Brookhaven National Laboratory, Associated Universities, Inc., Upton, NY 11973.

ABSTRACT

Studies were undertaken to determine the biologic distribution of thallium-201 in man. The disappearance from the blood is extremely rapid and intracellular deposition is nearly immediate. The biologic half-time of thallium was measured by both the Brookhaven whole-body counter and the Donner whole-body scanner, with excellent agreement. The effective whole-body half-time of thallium-201 is about 57 hr. Concentration of activity was seen in the heart, kidneys, large bowel, and thyroid. The whole-body radiation dose is 0.21 rads/mCi.

FOOTNOTES

* Present address: New England Nuclear Corp., North Billerica, MA 01862.




This article has been cited by other articles:


Home page
 JNMHome page
M. G. Stabin
Radiopharmaceuticals for Nuclear Cardiology: Radiation Dosimetry, Uncertainties, and Risk
J. Nucl. Med., September 1, 2008; 49(9): 1555 - 1563.
[Abstract] [Full Text] [PDF]

Home page
 Radiat Prot DosimetryHome page
E. Blanchardon, C. Challeton-de Vathaire, P. Boisson, D. Celier, J.-C. Martin, S. Cassot, G. Herbelet, D. Franck, J. R. Jourdain, and A. Biau
Long term retention and excretion of 201Tl in a patient after myocardial perfusion imaging
Radiat Prot Dosimetry, April 18, 2005; 113(1): 47 - 53.
[Abstract] [Full Text] [PDF]

Home page
 J. Nucl. Med. Technol.Home page
J. P. Norenberg, M. P. Vaidya, W. B. Hladik III, D. R. Pathak, J. L. Born, T. L. Anderson, and T. R. Carroll
The Effect of Selected Preparation Variables on the Radiochemical Purity of 99mTc-Sestamibi
J. Nucl. Med. Technol., March 1, 2005; 33(1): 34 - 41.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. R. Thomas, M. G. Stabin, and F. P. Castronovo
Radiation-Absorbed Dose from 201Tl-Thallous Chloride
J. Nucl. Med., March 1, 2005; 46(3): 502 - 508.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. S. Nettleton, R. S. Lawson, M. C. Prescott, and I. D. Morris
Uptake, Localization, and Dosimetry of 111In and 201Tl in Human Testes
J. Nucl. Med., January 1, 2004; 45(1): 138 - 146.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
B. L. Maria, W. B. Drane, R. J. Quisling, and K. B. N. Hoang
Correlation Between Gadolinium-Diethylenetriaminepentaacetic Acid Contrast Enhancement and Thallium-201 Chloride Uptake in Pediatric Brainstem Glioma
J Child Neurol, September 1, 1997; 12(6): 341 - 348.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1977 by the Society of Nuclear Medicine.